A groundbreaking study published in Cell Reports reveals that transplanting healthy human glial cells into the brains of adult mice with Huntington’s disease significantly slowed motor and cognitive decline and extending lifespan. Led by researchers at the University of Rochester, this discovery challenges the traditional neuron-centric view of the disease and opens new avenues for cell-based therapies in symptomatic adults.
Huntington’s disease, a hereditary brain disorder caused by a mutation in the HTT gene, has long been associated with the progressive deterioration of neurons, particularly in the striatum. However, this study highlights the critical role of dysfunctional glial cells-the brain’s support cells-in exacerbating neuronal damage. By replacing diseased glia with healthy human glial progenitor cells, researchers observed restored synaptic function and delayed disease progression in adult mice.
The team used R6/2 mice, a model for Huntington’s disease, injecting healthy glial cells into their striata at five weeks old, when symptoms first appear. Treated mice exhibited improved coordination, memory, and motor skills, along with increased lifespan. Advanced techniques like single-nucleus RNA sequencing confirmed that the transplanted glia reactivated genes essential for synaptic health and restored dendritic branching in neurons.
Dr. Steve Goldman, co-director of the University of Rochester Center for Translational Neuromedicine and lead author, emphasized: “This study shifts the perspective on Huntington’s by showing that glial pathology drives synaptic dysfunction. Even in adults, targeting glial cells can meaningfully delay disease progression.”
These findings suggest that glial replacement therapy could become a key component of future Huntington’s treatments, either alone or combined with other strategies like gene therapy. While further research is needed to optimize delivery and timing, the study offers hope for interventions in patients already experiencing symptoms. The results underscore the potential of cell-based therapies to repair the adult brain and redefine approaches to neurodegenerative diseases.
Add comment